Iran joins small group of countries with cell therapy, cancer treatment capabilities

Pars Today- Iran has made advances in cancer treatment after acquiring technical expertise in the field of cell therapy.

According to Pars Today, citing Fars News Agency, Iran’s achievement of this technology comes as cell therapy, due to its complex nature and the high costs of managing treatment, is considered part of countries’ biological security and national power. Countries that possess this technology not only have access to the advanced pharmaceutical market but are also not dependent on others during biological crises.

From Bone Marrow Transplants to Regenerative Medicine

The development of cell therapy worldwide began in 1969 with the first successful bone marrow transplant for a patient suffering from leukemia. As research expanded and expertise in culturing stem cells — undifferentiated cells capable of developing into various types of body cells and replacing damaged tissues — was acquired, the field moved beyond the treatment of leukemia and is now used to treat immune deficiencies, severe burns and genetic diseases.

The development of this technology is not merely a theoretical field of knowledge; it depends on infrastructure, specialized facilities and close monitoring. Improper control of cells can lead to uncontrolled proliferation and the risk of tumor formation, or trigger immune reactions in the recipient’s body.

Nevertheless, Iran has managed to move beyond the research stage and bring cell therapy expertise into the production and medical application stages, creating new potential for the future of medicine in Iran.